CARMELL THERAPEUTICS

carmell-therapeutics-logo

Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repai... red tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).

#SimilarOrganizations #People #Financial #Event #Website #More

CARMELL THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Life Science Medical Device Therapeutics

Founded:
2007-01-01

Address:
Pittsburgh, Pennsylvania, United States

Country:
United States

Website Url:
http://www.carmellrx.com

Total Employee:
1+

Status:
Active

Contact:
4122088033

Email Addresses:
[email protected]

Total Funding:
9.04 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome


Similar Organizations

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

blue-belt-technologies-logo

Blue Belt Technologies

Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.


Current Advisors List

paul-l-kornblith_image

Paul L. Kornblith Chairman @ Carmell Therapeutics
Board_member

richard-upton_image

Richard Upton Board Of Directors @ Carmell Therapeutics
Board_member

james-jordan_image

James Jordan Board of Directors @ Carmell Therapeutics
Board_member
2011-01-01

randy-hubbell_image

Randy Hubbell Chairman of the Board & Chief Executive Officer @ Carmell Therapeutics
Board_member
2016-02-01

Current Employees Featured

james-hart_image

James Hart
James Hart Chief Medical Officer @ Carmell Therapeutics
Chief Medical Officer

stephanie-kladakis_image

Stephanie Kladakis
Stephanie Kladakis Chief Scientific Officer @ Carmell Therapeutics
Chief Scientific Officer

not_available_image

Phil Campbell
Phil Campbell Founder @ Carmell Therapeutics
Founder

donna-godward_image

Donna Godward
Donna Godward Chief Quality Officer @ Carmell Therapeutics
Chief Quality Officer

james-burgess_image

James Burgess
James Burgess Founder @ Carmell Therapeutics
Founder
2008-07-01

lee-weiss_image

Lee Weiss
Lee Weiss Founder @ Carmell Therapeutics
Founder

sebby-borriello_image

Sebby Borriello
Sebby Borriello Chief Business Officer @ Carmell Therapeutics
Chief Business Officer
2022-05-01

Founder


james-burgess_image

James Burgess

lee-weiss_image

Lee Weiss

not_available_image

Phil Campbell

Investors List

innovation-works_image

Innovation Works

Innovation Works investment in Seed Round - Carmell Therapeutics

jay-yue_image

Jay Yue

Jay Yue investment in Convertible Note - Carmell Therapeutics

maine-angels_image

Maine Angels

Maine Angels investment in Series B - Carmell Therapeutics

keiretsu-forum_image

Keiretsu Forum

Keiretsu Forum investment in Series B - Carmell Therapeutics

harbor-light-capital-partners_image

Harbor Light Capital Partners

Harbor Light Capital Partners investment in Series B - Carmell Therapeutics

bluetree-allied-angels_image

BlueTree Allied Angels

BlueTree Allied Angels investment in Series B - Carmell Therapeutics

newlin-investment-company_image

Newlin Investment Company

Newlin Investment Company investment in Series B - Carmell Therapeutics

pittsburgh-life-sciences-greenhouse_image

Pittsburgh Life Sciences Greenhouse

Pittsburgh Life Sciences Greenhouse investment in Series B - Carmell Therapeutics

lehigh-valley-angel-investors_image

Lehigh Valley Angel Investors

Lehigh Valley Angel Investors investment in Angel Round - Carmell Therapeutics

innovation-works_image

Innovation Works

Innovation Works investment in Debt Financing - Carmell Therapeutics

Official Site Inspections

http://www.carmellrx.com

  • Host name: fwdlb.pairnic.net
  • IP address: 216.92.3.120
  • Location: Pittsburgh United States
  • Latitude: 40.4236
  • Longitude: -79.9825
  • Metro Code: 508
  • Timezone: America/New_York
  • Postal: 15203

Loading ...

More informations about "Carmell Therapeutics" on Search Engine